Interferon-alpha-2 in the treatment of i
✍
Seewann, H. L. ;Gastl, G. ;Lang, A. ;Abbrederis, K. ;Thaler, J. ;Flener, R. ;Hub
📂
Article
📅
1988
🏛
Springer-Verlag
⚖ 308 KB
We investigated the effect of human recombinant DNA-derived IFN-alpha-2 given in a dose of 1-2 X 10(6) units daily by subcutaneous injection to five patients with advanced idiopathic myelofibrosis (IM). Transfusion dependent anemia and symptomatic splenomegaly were taken as inclusion criteria for th